##common.pageHeaderLogo.altText##

Original article

Vol. 155 No. 9 (2025)

Preventable medication-related readmissions involving older adults: a retrospective cohort analysis

Cite this as:
Swiss Med Wkly. 2025;155:4259
Published
15.09.2025

Summary

BACKGROUND: Medication-related readmissions are significant burdens on patients and healthcare systems and are particularly prevalent among older adults. We aimed to identify potentially preventable medication-related readmissions and to describe their causes.

METHODS: We conducted a retrospective cohort study of 500 randomly selected patients, aged 65 or older, discharged from the general internal medicine department of a university hospital in Switzerland between January 2022 and October 2023 and readmitted within 30 days. Two pharmacists independently screened their electronic health records and analysed whether their readmission was medication-related using the AT-HARM10 tool. We assessed preventability using judgements similar to the Schumock statements. In cases of disagreement between the two pharmacists, readmissions were also screened by a senior physician. We analysed the causes of potentially preventable medication-related readmissions.

RESULTS: We identified 116 (23.2%) potentially preventable medication-related readmissions among the 500 readmissions analysed. The most common diagnoses associated with readmission were heart failure (21.6%), worsening pain (12.1%) and infection (12.1%). The most common causes of readmission were underprescribing (29.3%), Other prescribing problems such as suboptimal medication selection or dosage issues (28.4%), and non-adherence (12.9%). Diuretics, analgesics and antibiotics were the most frequently involved medications.

CONCLUSIONS: Nearly one-quarter of 30-day readmissions involving older adults were medication-related and potentially preventable. The primary contributing factors were prescribing and non-adherence issues. The study highlighted common causes of such readmissions and underlines the need for further research to determine which interventions – such as medication reviews or improved care transitions – are most effective in addressing them. Identifying high-risk patients will also be essential to optimise the use of healthcare resources.

References

  1. 1. Institute of Medicine. Preventing Medication Errors. Washington (DC): The National Academies Press; 2007.
  2. 2. Foulon V, Wuyts J, Desplenter F, Spinewine A, Lacour V, Paulus D, et al. Problems in continuity of medication management upon transition between primary and secondary care: patients’ and professionals’ experiences. Acta Clin Belg. 2019 Aug;74(4):263–71. 10.1080/17843286.2018.1483561
  3. 3. Gandhi TK, Seger DL, Bates DW. Identifying drug safety issues: from research to practice. Int J Qual Health Care. 2000 Feb;12(1):69–76. 10.1093/intqhc/12.1.69
  4. 4. World Health Organization. International drug monitoring: the role of national centres. Report of a WHO meeting. Geneva; 1972.
  5. 5. Elliott RA, Camacho E, Jankovic D, Sculpher MJ, Faria R. Economic analysis of the prevalence and clinical and economic burden of medication error in England. BMJ Qual Saf. 2021 Feb;30(2):96–105. 10.1136/bmjqs-2019-010206
  6. 6. Sell R, Schaefer M. Prevalence and risk factors of drug-related problems identified in pharmacy-based medication reviews. Int J Clin Pharm. 2020 Apr;42(2):588–97. 10.1007/s11096-020-00976-8
  7. 7. Banholzer S, Dunkelmann L, Haschke M, Derungs A, Exadaktylos A, Krähenbühl S, et al. Retrospective analysis of adverse drug reactions leading to short-term emergency hospital readmission. Swiss Med Wkly. 2021 Jan;151(304):w20400. 10.4414/smw.2021.20400
  8. 8. Blum MR, Sallevelt BT, Spinewine A, O’Mahony D, Moutzouri E, Feller M, et al. Optimizing Therapy to Prevent Avoidable Hospital Admissions in Multimorbid Older Adults (OPERAM): cluster randomised controlled trial. BMJ. 2021 Jul;374(1585):n1585. 10.1136/bmj.n1585
  9. 9. Kempen TGH, Bertilsson M, Hadziosmanovic N, Lindner K-J, Melhus H, Nielsen EI, et al. Effects of Hospital-Based Comprehensive Medication Reviews Including Postdischarge Follow-up on Older Patients’ Use of Health Care: A Cluster Randomized Clinical Trial. JAMA Netw Open. 2021;4(4):e216303-e. doi: 10.1001/jamanetworkopen.2021.6303.
  10. 10. El Morabet N, Uitvlugt EB, van den Bemt BJ, van den Bemt PM, Janssen MJ, Karapinar-Çarkit F. Prevalence and Preventability of Drug-Related Hospital Readmissions: A Systematic Review. J Am Geriatr Soc. 2018 Mar;66(3):602–8. 10.1111/jgs.15244
  11. 11. Prasad N, Lau EC, Wojt I, Penm J, Dai Z, Tan EC. Prevalence of and Risk Factors for Drug-Related Readmissions in Older Adults: A Systematic Review and Meta-Analysis. Drugs Aging. 2024 Jan;41(1):1–11. 10.1007/s40266-023-01076-8
  12. 12. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med. 2009 Apr;360(14):1418–28. 10.1056/NEJMsa0803563
  13. 13. Kum Ghabowen I, Epane JP, Shen JJ, Goodman X, Ramamonjiarivelo Z, Zengul FD. Systematic Review and Meta-Analysis of the Financial Impact of 30-Day Readmissions for Selected Medical Conditions: A Focus on Hospital Quality Performance. Healthcare (Basel). 2024 Mar;12(7):750. 10.3390/healthcare12070750
  14. 14. Schönenberger N, Meyer-Massetti C. Risk factors for medication-related short-term readmissions in adults - a scoping review. BMC Health Serv Res. 2023 Sep;23(1):1037. 10.1186/s12913-023-10028-2
  15. 15. Cooper JB, Jeter E, Sessoms CJ. Rates and Types of Medication-Related Problems in Patients Rehospitalized Within 30 Days of Discharge From a Community Hospital. J Pharm Technol. 2020 Apr;36(2):47–53. 10.1177/8755122519883642
  16. 16. Ekerstad N, Bylin K, Karlson BW. Early rehospitalizations of frail elderly patients - the role of medications: a clinical, prospective, observational trial. Drug Healthc Patient Saf. 2017 Aug;9:77–88. doi: https://doi.org/10.2147/DHPS.S139237
  17. 17. Rothwell M, Jukka C, Lum E, Mitchell C, Kyriakides P. Retrospective Analysis of Emergency Readmissions to Rural and Regional Hospitals. J Pharm Pract Res. 2011;41(4):290–4. 10.1002/j.2055-2335.2011.tb00106.x
  18. 18. Uitvlugt EB, Janssen MJ, Siegert CE, Kneepkens EL, van den Bemt BJ, van den Bemt PM, et al. Medication-Related Hospital Readmissions Within 30 Days of Discharge: Prevalence, Preventability, Type of Medication Errors and Risk Factors. Front Pharmacol. 2021 Apr;12:567424. 10.3389/fphar.2021.567424
  19. 19. Dalleur O, Beeler PE, Schnipper JL, Donzé J. 30-Day Potentially Avoidable Readmissions Due to Adverse Drug Events. J Patient Saf. 2021 Aug;17(5):e379–86. doi: https://doi.org/10.1097/PTS.0000000000000346
  20. 20. Twerenbold S, Schur N, Wittwer N, Schneider C, Marxer C, Spöndlin J, et al. Helsana-Arzneimittelreport für die Schweiz 2022. Auswertungsergebnisse der Helsana Arzneimitteldaten aus den Jahren 2018 bis 2021. Zürich: Helsana-Gruppe; 2022.
  21. 21. Kempen TG, Hedström M, Olsson H, Johansson A, Ottosson S, Al-Sammak Y, et al. Assessment tool for hospital admissions related to medications: development and validation in older patients. Int J Clin Pharm. 2019 Feb;41(1):198–206. 10.1007/s11096-018-0768-8
  22. 22. Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm. 1992 Jun;27(6):538.
  23. 23. Iftikhar S, Sarwar MR, Saqib A, Sarfraz M. Causality and preventability assessment of adverse drug reactions and adverse drug events of antibiotics among hospitalized patients: A multicenter, cross-sectional study in Lahore, Pakistan. PLoS One. 2018 Jun;13(6):e0199456. 10.1371/journal.pone.0199456
  24. 24. World Health Organization. Global burden of preventable medication-related harm in health care: a systematic review. Geneva; 2023.
  25. 25. Glans M, Kragh Ekstam A, Jakobsson U, Bondesson Å, Midlöv P. Medication-related hospital readmissions within 30 days of discharge-A retrospective study of risk factors in older adults. PLoS One. 2021 Jun;16(6):e0253024. 10.1371/journal.pone.0253024
  26. 26. Pellegrin KL, Lee E, Uyeno R, Ayson C, Goo R. Potentially preventable medication-related hospitalizations: A clinical pharmacist approach to assessment, categorization, and quality improvement. J Am Pharm Assoc (Wash DC). 2017;57(6):711–6. 10.1016/j.japh.2017.06.019
  27. 27. Whitaker AS, Cottrell WN. What proportion of unplanned re-presentations to an emergency department are medication related and preventable? J Pharm Pract Res. 2019;49(6):546–56. 10.1002/jppr.1581
  28. 28. Kempen TG, Hedman AN, Hadziosmanovic N, Lindner KJ, Melhus H, Nielsen EI, et al. Risk factors for and preventability of drug-related hospital revisits in older patients: A post-hoc analysis of a randomized clinical trial. Br J Clin Pharmacol. 2023 May;89(5):1575–87. 10.1111/bcp.15621
  29. 29. Lombardi F, Paoletti L, Carrieri B, Dell’Aquila G, Fedecostante M, Di Muzio M, et al. Underprescription of medications in older adults: causes, consequences and solutions-a narrative review. Eur Geriatr Med. 2021 Jun;12(3):453–62. 10.1007/s41999-021-00471-x
  30. 30. Cherubini A, Corsonello A, Lattanzio F. Underprescription of beneficial medicines in older people: causes, consequences and prevention. Drugs Aging. 2012 Jun;29(6):463–75. 10.2165/11631750-000000000-00000
  31. 31. Schietzel S, Zechmann S, Rachamin Y, Neuner-Jehle S, Senn O, Grischott T. Potentially Inappropriate Medication Use in Primary Care in Switzerland. JAMA Network Open. 2024;7(6):e2417988-e. doi: 10.1001/jamanetworkopen.2024.17988.
  32. 32. Gallagher P, Barry P, O’Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther. 2007 Apr;32(2):113–21. 10.1111/j.1365-2710.2007.00793.x
  33. 33. Blanc AL, Fumeaux T, Stirnemann J, Dupuis Lozeron E, Ourhamoune A, Desmeules J, et al. Development of a predictive score for potentially avoidable hospital readmissions for general internal medicine patients. PLoS One. 2019 Jul;14(7):e0219348. 10.1371/journal.pone.0219348
  34. 34. Hugtenburg JG, Timmers L, Elders PJ, Vervloet M, van Dijk L. Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions. Patient Prefer Adherence. 2013 Jul;7:675–82. doi: https://doi.org/10.2147/PPA.S29549
  35. 35. Frankl SE, Breeling JL, Goldman L. Preventability of emergent hospital readmission. Am J Med. 1991 Jun;90(6):667–74. doi: https://doi.org/10.1016/S0002-9343(05)80053-1
  36. 36. Ruppar TM, Delgado JM, Temple J. Medication adherence interventions for heart failure patients: A meta-analysis. Eur J Cardiovasc Nurs. 2015 Oct;14(5):395–404. 10.1177/1474515115571213
  37. 37. Wood D, Moy SF, Zhang S, Lightfoot N. Impact of a prescriber and patient educational intervention on discharge analgesia prescribing and hospital readmission rates following elective unilateral total hip and knee arthroplasty. BMJ Open Qual. 2022 Aug;11(3):e001672. 10.1136/bmjoq-2021-001672
  38. 38. Mekonnen AB, McLachlan AJ, Brien JA. Effectiveness of pharmacist-led medication reconciliation programmes on clinical outcomes at hospital transitions: a systematic review and meta-analysis. BMJ Open. 2016 Feb;6(2):e010003. 10.1136/bmjopen-2015-010003
  39. 39. Renaudin P, Boyer L, Esteve MA, Bertault-Peres P, Auquier P, Honore S. Do pharmacist-led medication reviews in hospitals help reduce hospital readmissions? A systematic review and meta-analysis. Br J Clin Pharmacol. 2016 Dec;82(6):1660–73. 10.1111/bcp.13085
  40. 40. Ruppar TM, Cooper PS, Mehr DR, Delgado JM, Dunbar-Jacob JM. Medication Adherence Interventions Improve Heart Failure Mortality and Readmission Rates: Systematic Review and Meta-Analysis of Controlled Trials. J Am Heart Assoc. 2016 Jun;5(6):e002606. 10.1161/JAHA.115.002606
  41. 41. Zemaitis CT, Morris G, Cabie M, Abdelghany O, Lee L. Reducing Readmission at an Academic Medical Center: Results of a Pharmacy-Facilitated Discharge Counseling and Medication Reconciliation Program. Hosp Pharm. 2016 Jun;51(6):468–73. 10.1310/hpj5106-468
  42. 42. March KL, Peters MJ, Finch CK, Roberts LA, McLean KM, Covert AM, et al. Pharmacist Transition-of-Care Services Improve Patient Satisfaction and Decrease Hospital Readmissions. J Pharm Pract. 2022 Feb;35(1):86–93. 10.1177/0897190020958264
  43. 43. Dautzenberg L, Bretagne L, Koek HL, Tsokani S, Zevgiti S, Rodondi N, et al. Medication review interventions to reduce hospital readmissions in older people. J Am Geriatr Soc. 2021 Jun;69(6):1646–58. 10.1111/jgs.17041
  44. 44. Studer H, Boeni F, Messerli M, Hersberger KE, Lampert ML. Clinical Pharmacy Activities in Swiss Hospitals: How Have They Evolved from 2013 to 2017? Pharmacy (Basel). 2020 Feb;8(1):19. 10.3390/pharmacy8010019